GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Uncharacterized protein

 W5NY24_SHEEP            Unreviewed;       782 AA.
W5NY24;
16-APR-2014, integrated into UniProtKB/TrEMBL.
16-APR-2014, sequence version 1.
26-FEB-2020, entry version 43.
SubName: Full=Catenin beta 1 {ECO:0000313|Ensembl:ENSOARP00000003072};
Name=CTNNB1 {ECO:0000313|Ensembl:ENSOARP00000003072};
Ovis aries (Sheep).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
Caprinae; Ovis.
NCBI_TaxID=9940 {ECO:0000313|Ensembl:ENSOARP00000003072, ECO:0000313|Proteomes:UP000002356};
[1] {ECO:0000313|Ensembl:ENSOARP00000003072, ECO:0000313|Proteomes:UP000002356}
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=Texel {ECO:0000313|Ensembl:ENSOARP00000003072,
ECO:0000313|Proteomes:UP000002356};
PubMed=20809919; DOI=10.1111/j.1365-2052.2010.02100.x;
Archibald A.L., Cockett N.E., Dalrymple B.P., Faraut T., Kijas J.W.,
Maddox J.F., McEwan J.C., Hutton Oddy V., Raadsma H.W., Wade C., Wang J.,
Wang W., Xun X.;
"The sheep genome reference sequence: a work in progress.";
Anim. Genet. 41:449-453(2010).
[2] {ECO:0000313|Ensembl:ENSOARP00000003072}
IDENTIFICATION.
Ensembl;
Submitted (FEB-2014) to UniProtKB.
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; AMGL01044365; -; NOT_ANNOTATED_CDS; Genomic_DNA.
STRING; 9940.ENSOARP00000003072; -.
Ensembl; ENSOART00000003132; ENSOARP00000003072; ENSOARG00000002885.
GeneTree; ENSGT00940000155471; -.
HOGENOM; CLU_008757_1_1_1; -.
OMA; MAWNEXP; -.
Proteomes; UP000002356; Chromosome 19.
GO; GO:0005912; C:adherens junction; IEA:Ensembl.
GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
GO; GO:0030877; C:beta-catenin destruction complex; IEA:Ensembl.
GO; GO:0070369; C:beta-catenin-TCF7L2 complex; IEA:Ensembl.
GO; GO:0005923; C:bicellular tight junction; IEA:Ensembl.
GO; GO:0016342; C:catenin complex; IEA:Ensembl.
GO; GO:0005623; C:cell; IEA:GOC.
GO; GO:0005813; C:centrosome; IEA:Ensembl.
GO; GO:0005829; C:cytosol; IEA:Ensembl.
GO; GO:0005916; C:fascia adherens; IEA:Ensembl.
GO; GO:0016600; C:flotillin complex; IEA:Ensembl.
GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
GO; GO:0016328; C:lateral plasma membrane; IEA:Ensembl.
GO; GO:0031528; C:microvillus membrane; IEA:Ensembl.
GO; GO:0005719; C:nuclear euchromatin; IEA:Ensembl.
GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
GO; GO:0099092; C:postsynaptic density, intracellular component; IEA:Ensembl.
GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
GO; GO:0098831; C:presynaptic active zone cytoplasmic component; IEA:Ensembl.
GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl.
GO; GO:0032993; C:protein-DNA complex; IEA:Ensembl.
GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IEA:Ensembl.
GO; GO:0034750; C:Scrib-APC-beta-catenin complex; IEA:Ensembl.
GO; GO:1990909; C:Wnt signalosome; IEA:Ensembl.
GO; GO:0030018; C:Z disc; IEA:Ensembl.
GO; GO:0045294; F:alpha-catenin binding; IEA:Ensembl.
GO; GO:0008013; F:beta-catenin binding; IEA:Ensembl.
GO; GO:0045296; F:cadherin binding; IEA:Ensembl.
GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.
GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:Ensembl.
GO; GO:0030331; F:estrogen receptor binding; IEA:Ensembl.
GO; GO:0070411; F:I-SMAD binding; IEA:Ensembl.
GO; GO:0044325; F:ion channel binding; IEA:Ensembl.
GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
GO; GO:0070491; F:repressing transcription factor binding; IEA:Ensembl.
GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IEA:Ensembl.
GO; GO:0001085; F:RNA polymerase II transcription factor binding; IEA:Ensembl.
GO; GO:0003713; F:transcription coactivator activity; IEA:Ensembl.
GO; GO:0034333; P:adherens junction assembly; IEA:Ensembl.
GO; GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl.
GO; GO:0036520; P:astrocyte-dopaminergic neuron signaling; IEA:Ensembl.
GO; GO:0045453; P:bone resorption; IEA:Ensembl.
GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IEA:Ensembl.
GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
GO; GO:0061324; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; IEA:Ensembl.
GO; GO:0044334; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; IEA:Ensembl.
GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
GO; GO:0048469; P:cell maturation; IEA:Ensembl.
GO; GO:0000904; P:cell morphogenesis involved in differentiation; IEA:Ensembl.
GO; GO:0098609; P:cell-cell adhesion; IEA:Ensembl.
GO; GO:0007160; P:cell-matrix adhesion; IEA:Ensembl.
GO; GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl.
GO; GO:0071681; P:cellular response to indole-3-methanol; IEA:Ensembl.
GO; GO:0022009; P:central nervous system vasculogenesis; IEA:Ensembl.
GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
GO; GO:0048096; P:chromatin-mediated maintenance of transcription; IEA:Ensembl.
GO; GO:0061550; P:cranial ganglion development; IEA:Ensembl.
GO; GO:1904888; P:cranial skeletal system development; IEA:Ensembl.
GO; GO:1990791; P:dorsal root ganglion development; IEA:Ensembl.
GO; GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl.
GO; GO:0007398; P:ectoderm development; IEA:Ensembl.
GO; GO:0000578; P:embryonic axis specification; IEA:Ensembl.
GO; GO:1990403; P:embryonic brain development; IEA:Ensembl.
GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
GO; GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl.
GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
GO; GO:0035050; P:embryonic heart tube development; IEA:Ensembl.
GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
GO; GO:0036023; P:embryonic skeletal limb joint morphogenesis; IEA:Ensembl.
GO; GO:0001711; P:endodermal cell fate commitment; IEA:Ensembl.
GO; GO:0061154; P:endothelial tube morphogenesis; IEA:Ensembl.
GO; GO:0060742; P:epithelial cell differentiation involved in prostate gland development; IEA:Ensembl.
GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl.
GO; GO:0061198; P:fungiform papilla formation; IEA:Ensembl.
GO; GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl.
GO; GO:0035112; P:genitalia morphogenesis; IEA:Ensembl.
GO; GO:0007403; P:glial cell fate determination; IEA:Ensembl.
GO; GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl.
GO; GO:0060789; P:hair follicle placode formation; IEA:Ensembl.
GO; GO:0030902; P:hindbrain development; IEA:Ensembl.
GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
GO; GO:0021819; P:layer formation in cerebral cortex; IEA:Ensembl.
GO; GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl.
GO; GO:0060479; P:lung cell differentiation; IEA:Ensembl.
GO; GO:0060492; P:lung induction; IEA:Ensembl.
GO; GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl.
GO; GO:0030539; P:male genitalia development; IEA:Ensembl.
GO; GO:0060916; P:mesenchymal cell proliferation involved in lung development; IEA:Ensembl.
GO; GO:0003338; P:metanephros morphogenesis; IEA:Ensembl.
GO; GO:1904948; P:midbrain dopaminergic neuron differentiation; IEA:Ensembl.
GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl.
GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
GO; GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl.
GO; GO:0003340; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl.
GO; GO:0045976; P:negative regulation of mitotic cell cycle, embryonic; IEA:Ensembl.
GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl.
GO; GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl.
GO; GO:1903204; P:negative regulation of oxidative stress-induced neuron death; IEA:Ensembl.
GO; GO:0033234; P:negative regulation of protein sumoylation; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0072079; P:nephron tubule formation; IEA:Ensembl.
GO; GO:0001840; P:neural plate development; IEA:Ensembl.
GO; GO:0001764; P:neuron migration; IEA:Ensembl.
GO; GO:1990138; P:neuron projection extension; IEA:Ensembl.
GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
GO; GO:0048599; P:oocyte development; IEA:Ensembl.
GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
GO; GO:0060066; P:oviduct development; IEA:Ensembl.
GO; GO:0031016; P:pancreas development; IEA:Ensembl.
GO; GO:1904501; P:positive regulation of chromatin-mediated maintenance of transcription; IEA:Ensembl.
GO; GO:1904798; P:positive regulation of core promoter binding; IEA:Ensembl.
GO; GO:2000017; P:positive regulation of determination of dorsal identity; IEA:Ensembl.
GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IEA:Ensembl.
GO; GO:2000144; P:positive regulation of DNA-templated transcription, initiation; IEA:Ensembl.
GO; GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl.
GO; GO:0060769; P:positive regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl.
GO; GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl.
GO; GO:0010909; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; IEA:Ensembl.
GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl.
GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
GO; GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl.
GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl.
GO; GO:0051973; P:positive regulation of telomerase activity; IEA:Ensembl.
GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IEA:Ensembl.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
GO; GO:0034394; P:protein localization to cell surface; IEA:Ensembl.
GO; GO:0000209; P:protein polyubiquitination; IEA:Ensembl.
GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
GO; GO:0090279; P:regulation of calcium ion import; IEA:Ensembl.
GO; GO:0030997; P:regulation of centriole-centriole cohesion; IEA:Ensembl.
GO; GO:0070602; P:regulation of centromeric sister chromatid cohesion; IEA:Ensembl.
GO; GO:1904793; P:regulation of euchromatin binding; IEA:Ensembl.
GO; GO:0031641; P:regulation of myelination; IEA:Ensembl.
GO; GO:0072182; P:regulation of nephron tubule epithelial cell differentiation; IEA:Ensembl.
GO; GO:2000008; P:regulation of protein localization to cell surface; IEA:Ensembl.
GO; GO:0003266; P:regulation of secondary heart field cardioblast proliferation; IEA:Ensembl.
GO; GO:0048660; P:regulation of smooth muscle cell proliferation; IEA:Ensembl.
GO; GO:0042129; P:regulation of T cell proliferation; IEA:Ensembl.
GO; GO:0051884; P:regulation of timing of anagen; IEA:Ensembl.
GO; GO:0072053; P:renal inner medulla development; IEA:Ensembl.
GO; GO:0072054; P:renal outer medulla development; IEA:Ensembl.
GO; GO:0072033; P:renal vesicle formation; IEA:Ensembl.
GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
GO; GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl.
GO; GO:0061549; P:sympathetic ganglion development; IEA:Ensembl.
GO; GO:0050808; P:synapse organization; IEA:Ensembl.
GO; GO:0097091; P:synaptic vesicle clustering; IEA:Ensembl.
GO; GO:0048489; P:synaptic vesicle transport; IEA:Ensembl.
GO; GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl.
GO; GO:0048538; P:thymus development; IEA:Ensembl.
GO; GO:0060440; P:trachea formation; IEA:Ensembl.
Gene3D; 1.25.10.10; -; 1.
InterPro; IPR011989; ARM-like.
InterPro; IPR016024; ARM-type_fold.
InterPro; IPR000225; Armadillo.
InterPro; IPR013284; Beta-catenin.
Pfam; PF00514; Arm; 4.
PRINTS; PR01869; BCATNINFAMLY.
SMART; SM00185; ARM; 12.
SUPFAM; SSF48371; SSF48371; 1.
PROSITE; PS50176; ARM_REPEAT; 9.
4: Predicted;
Reference proteome {ECO:0000313|Proteomes:UP000002356}.
REPEAT 152..192
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 194..237
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 236..278
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 278..320
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 320..363
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 401..443
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 443..485
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 490..533
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REPEAT 595..637
/note="ARM"
/evidence="ECO:0000256|PROSITE-ProRule:PRU00259"
REGION 35..59
/note="Disordered"
/evidence="ECO:0000256|SAM:MobiDB-lite"
REGION 706..782
/note="Disordered"
/evidence="ECO:0000256|SAM:MobiDB-lite"
COMPBIAS 35..49
/note="Polar"
/evidence="ECO:0000256|SAM:MobiDB-lite"
SEQUENCE 782 AA; 85610 MW; C133C70912EB8369 CRC64;
MATQVADLME LDMAMEPDRK AAVSHWQQQS YLDSGIHSGA TTTAPSLSGK GNPEEEDVDT
TQVLYEWEQG FSQSFTQEQV ADIDGQYAMT RAQRVRAAMF PETLDEGMQI PSTQFDAAHP
TNVQRLAEPS QMLKHAVVNL INYQDDAELA TRAIPELTKL LNDEDQVVVN KAAVMVHQLS
KKEASRHAIM RSPQMVSAIV RTMQNTNDVE TARCTAGTLH NLSHHREGLL AIFKSGGIPA
LVKMLGSPVD SVLFYAITTL HNLLLHQEGA KMAVRLAGGL QKMVALLNKT NVKFLAITTD
CLQILAYGNQ ESKLIILASG GPQALVNIMR TYTYEKLLWT TSRVLKVLSV CSSNKPAIVE
AGGMQALGLH LTDPSQRLVQ NCLWTLRNLS DAATKQEGME GLLGTLVQLL GSDDINVVTC
AAGILSNLTC NNYKNKMMVC QVGGIEALVR TVLRAGDRED ITEPAICALR HLTSRHQEAE
MAQNAVRLHY GLPVVVKLLH PPSHWPLIKA TVGLIRNLAL CPANHAPLRE QGAIPRLVQL
LVRAHQDTQR RTSMGGTQQQ FVEGVRMEEI VEGCTGALHI LARDVHNRIV IRGLNTIPLF
VQLLYSPIEN IQRVAAGVLC ELAQDKEAAE AIEAEGATAP LTELLHSRNE GVATYAAAVL
FRMSEDKPQD YKKRLSVELT SSLFRTEPMA WNETADLGLD IGAQGEPLGY RQDDPSYRSF
HSGGYGQDAL GMDPMMEHEM GGHHPGADYP VDGLPDLGHA QDLMDGLPPG DSNQLAWFDT
DL


Related products :

Catalog number Product name Quantity
EIAAB08798 C16orf11,Homo sapiens,Human,Uncharacterized protein C16orf11,Uncharacterized protein RJD1
EIAAB10060 CXorf52,Homo sapiens,Human,LINC00204A,NCRNA00204,Putative uncharacterized protein CXorf52,Putative uncharacterized protein encoded by LINC00204A,SPCX
18-003-44116 Putative uncharacterized protein - Putative uncharacterized protein LOC55565; LOC55565 protein Polyclonal 0.05 mg Aff Pur
EIAAB06906 Emprin,Extracellular matrix protein with prion homology,Mouse,Mus musculus,Protein STG,Stg,Uncharacterized protein C6orf15 homolog
EIAAB07568 Ag2,Protein Ag2,Rat,Rattus norvegicus,Uncharacterized protein C11orf96 homolog
EIAAB07548 Mouse,Mus musculus,Nwc,Protein NWC,Uncharacterized protein C11orf74 homolog
EIAAB06945 Nod3l,NOD3-like protein,Rat,Rattus norvegicus,Uncharacterized protein C6orf154 homolog
EIAAB06257 Mouse,Mus musculus,Osap,Ovary-specific acidic protein,Uncharacterized protein C4orf49 homolog
EIAAB07500 Mouse,Mus musculus,Oocyte-testis gene 1 protein,Otg1,Uncharacterized protein C10orf118 homolog
EIAAB06256 Bos taurus,Bovine,OSAP,Ovary-specific acidic protein,Uncharacterized protein C4orf49 homolog
EIAAB10025 Mouse,Mus musculus,Testis-specific expressed protein 2,TSEG2,TSEG-2,Uncharacterized protein C22orf41 homolog
EIAAB07459 Kiaa2006,Mouse,Mus musculus,Pap20,Peripheral benzodiazepine receptor-associated protein 20,Uncharacterized protein C10orf18 homolog
EIAAB07546 L7rn6,Lethal gene on chromosome 7 Rinchik 6 protein,Mouse,Mus musculus,Uncharacterized protein C11orf73 homolog
EIAAB07317 Mouse,Mus musculus,Smrp1,Spermatid-specific manchette-related protein 1,Uncharacterized protein C9orf24 homolog
EIAAB08112 C14orf162,Homo sapiens,Human,Myelin proteolipid protein-like protein,PLPL,Uncharacterized protein C14orf162
EIAAB07067 C8orf42,Homo sapiens,Human,Protein INM01,Protein TDRP,Uncharacterized protein C8orf42
20-783-73159 MOUSE ANTI HUMAN C1q - C1q and tumor necrosis factor related protein 5. isoform CRA_a; Uncharacterized protein C1QTNF5 Monoclonal 0.1 mg
EIAAB06227 C4orf3,HCV F-transactivated protein 1,Hepatitis C virus F protein-transactivated protein 1,Homo sapiens,Human,Uncharacterized protein C4orf3
18-003-44281 Putative uncharacterized protein - N_A Polyclonal 0.1 mg Protein A
18-003-44025 Uncharacterized protein KIAA1849 - N_A Polyclonal 0.1 mg Protein A
18-003-43635 Putative uncharacterized protein - N_A Polyclonal 0.1 mg Protein A
18-003-43838 Putative uncharacterized protein - N_A Polyclonal 0.1 mg Protein A
EH1144 Uncharacterized protein C13orf33 Elisa Kit 96T
EH1184 Uncharacterized protein KIAA1377 Elisa Kit 96T
18-003-42509 Uncharacterized protein C14orf101 - N_A Polyclonal 0.05 mg Aff Pur
Pathways :
WP2371: Parkinsons Disease Pathway
WP540: Cytoplasmic Ribosomal Proteins
WP1049: G Protein Signaling Pathways
WP1713: Two-component system
WP163: Cytoplasmic Ribosomal Proteins
WP1659: Glycine, serine and threonine metabolism
WP1789: Binding of RNA by Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs)
WP1665: Limonene and pinene degradation
WP525: Mitochondrial Unfolded-Protein Response
WP914: NLR proteins
WP1438: Influenza A virus infection
WP1892: Protein folding
WP1531: Vitamin D synthesis
WP2032: TSH signaling pathway
WP1887: Post-translational modification: synthesis of GPI-anchored proteins
WP1675: Nitrogen metabolism
WP813: G Protein Signaling Pathways
WP1685: Peptidoglycan biosynthesis
WP1032: NLR proteins
WP1616: ABC transporters
WP2199: Seed Development
WP1963: The effect of Glucocorticoids on target gene expression
WP1644: DNA replication
WP2272: Pathogenic Escherichia coli infection
WP288: NLR proteins

Related Genes :
[C4orf3] Uncharacterized protein C4orf3 (Hepatitis C virus F protein-transactivated protein 1) (HCV F-transactivated protein 1)
[NKAPD1 C11orf57] Uncharacterized protein NKAPD1 (NKAP domain containing protein 1)
[C14orf119 My028] Uncharacterized protein C14orf119
[C1orf94] Uncharacterized protein C1orf94
[C10orf55] Uncharacterized protein C10orf55
[C1orf109] Uncharacterized protein C1orf109
[C19orf57] Uncharacterized protein C19orf57 (Pre-T/NK cell-associated protein 3B3)
[1070] Uncharacterized protein 1070
[SPAC17H9.02] Uncharacterized helicase C17H9.02 (EC 3.6.4.-)
[C4orf45] Uncharacterized protein C4orf45
[IRC20 YLR247C] Uncharacterized ATP-dependent helicase IRC20 (EC 3.6.1.-) (Increased recombination centers protein 20)
[C11orf87] Uncharacterized protein C11orf87
[SBK3 SGK110] Uncharacterized serine/threonine-protein kinase SBK3 (EC 2.7.11.1) (SH3-binding domain kinase family member 3) (Sugen kinase 110)
[Stg] Uncharacterized protein C6orf15 homolog (Extracellular matrix protein with prion homology) (Emprin) (Protein STG)
[SPBC902.06] Uncharacterized protein C902.06
[C20orf85] Uncharacterized protein C20orf85
[] Genome polyprotein [Cleaved into: Protein p11; Protein p28; NTPase (EC 3.6.1.15) (p35); Protein p32; Viral genome-linked protein (VPg) (p14); Protease-polymerase p70 (Pro-Pol) (EC 2.7.7.48) (EC 3.4.22.66); Capsid protein (CP) (VP1) (p60)]
[hexB DOTSEDRAFT_181128] Fatty acid synthase beta subunit hexB (EC 2.3.1.86) (S-acyl fatty acid synthase thioesterase) (EC 3.1.2.14) [Includes: 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9); [Acyl-carrier-protein] acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] malonyltransferase (EC 2.3.1.39) (Dothistromin biosynthesis protein hexB)]
[ORF1] Genome polyprotein [Cleaved into: Protein p28; NTPase (EC 3.6.1.15) (p35); Protein p32; Viral genome-linked protein (VPg) (p14); Protease-polymerase p70 (Pro-Pol) (EC 2.7.7.48) (EC 3.4.22.66); Capsid protein (CP) (VP1) (p60)] (Fragment)
[CHMP3 CGI149 NEDF VPS24 CGI-149] Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24)
[CHMP2A BC2 CHMP2] Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1)
[DCUN1D3 SCCRO3] DCN1-like protein 3 (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3) (Squamous cell carcinoma-related oncogene 3)
[CTDSPL C3orf8 NIF1 NIFL SCP3 YA22] CTD small phosphatase-like protein (CTDSP-like) (EC 3.1.3.16) (Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3) (NIF-like protein) (Nuclear LIM interactor-interacting factor 1) (NLI-interacting factor 1) (Protein YA22) (hYA22) (RBSP3) (Small C-terminal domain phosphatase 3) (SCP3) (Small CTD phosphatase 3)
[smpB smqB b2620 JW2601] SsrA-binding protein (Small protein B)
[Slc27a4 Acsvl4 Fatp4] Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.-) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4)
[NBA1 YOL070C] Protein NBA1 (NAP1 and bud neck-associated protein 1)
[VTC1 NRF1 PHM4 YER072W] Vacuolar transporter chaperone 1 (Negative regulator of CDC42 protein 1) (Phosphate metabolism protein 4)
[C7orf31] Uncharacterized protein C7orf31
[Cdyl] Chromodomain Y-like protein (CDY-like) (Crotonyl-CoA hydratase) (EC 4.2.1.-) (Putative histone acetyltransferase Cdyl) (EC 2.3.1.48)
[CTDNEP1 DULLARD] CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard)

Bibliography :
[32754614] Comparative Genomics and Evolutionary Analysis of RNA-Binding Proteins of the CsrA Family in the Genus .
[32749952] sp. nov., isolated from a freshwater lake.
[32744794] Mapping the nucleolar proteome reveals a spatiotemporal organization related to intrinsic protein disorder.
[32744249] Structural characterization of three noncanonical NTF2-like superfamily proteins: implications for polyketide biosynthesis.
[32743959] Resistance to serine in Bacillus subtilis: Identification of the serine transporter YbeC and of a metabolic network that links serine and threonine metabolism.
[32743570] Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV.
[32743000] From the Uncharacterized Protein Family 0016 to the GDT1 family: Molecular insights into a newly-characterized family of cation secondary transporters.
[32737119] Selective Disruption of Synaptic BMP Signaling by a Smad Mutation Adjacent to the Highly Conserved H2 Helix.
[32736701] Megalin-mediated albumin endocytosis in cultured murine mesangial cells.
[32736135] Analysis of the proteins secreted by Trichoderma harzianum P49P11 under carbon-limited conditions.